The composition of the gut microbiomes in a group of rectal cancer patients reveals distinct signatures by race, ethnicity, and age of onset, with white Hispanics showing significant presence of one specific bacteria, UT Southwestern Medical Center researchers report

Expected to be diagnosed in 2% of men and 1% of women in the U.S., kidney cancer has traditionally been one of the most challenging cancers to treat

A team led by UT Southwestern Medical Center cardiologist Ambarish Pandey, M.D., was awarded the grand prize in the American Heart Association Heart Failure Data Challenge hosted by the American Heart Association and the Association of Black Cardiologists

For decades, researchers have assumed that women taking oral contraceptives have stable levels of sex hormones over each monthly cycle. However, a new study in the American Journal of Physiology-Endocrinology and Metabolism led by Yasin Dhaher, Ph.D., Professor of Physical Medicine & Rehabilitation

– AccessHope, LLC, a company changing the way leading-edge cancer expertise is delivered, announced that UT Southwestern Harold C. Simmons Comprehensive Cancer Center will become the seventh National Cancer Institute (NCI)-designated center in the AccessHope network

UT Southwestern Simmons Cancer Center teams up with Dallas and Fort Worth Mayors to encourage Metroplex to get screened for the health of it

An analysis of more than 400 singers who sought treatment at UT Southwestern Medical Center for vocal injuries provides a wealth of data on a topic that’s often considered taboo to discuss in the singing community

COVID-19 patients who receive a palliative care consultation are 5.6 times more likely to receive comfort care at the end of life and are just as likely to receive CPR if needed as those who did not receive a consultation, according to a UT Southwestern study

A team led by UTSW researchers has identified a molecule produced by male parasitic worms called schistosomes that prompts sexual maturity in females of these species

The Harold C. Simmons Comprehensive Cancer Center has been awarded grants from the Cancer Prevention and Research Institute of Texas to increase minority participation in clinical trials, expand lung cancer screening, develop brain tumor drugs, and advance innovations in drug discovery and